#hepatitis

Since 1991, most children have been getting vaccinated against hepatitis B, so most adults under 30 are not at risk for the liver disease.

Barriers still stand in the way of making treatment available to all who need it.

The Supreme Court upholds the Affordable Care Act for a third time. Here’s a look at responses from health care advocates.

A letter from 124 patient groups urges the White House to make drugs more affordable—and spells out how it can do so.

Hepatitis A and E usually resolve on their own, but hepatitis B and C can cause serious liver disease, including cirrhosis and liver cancer.

290 million people have viral hepatitis and don’t know it. Raise awareness with a virtual video relay.

People who have more flu, pneumonia, gastroenteritis, and hepatitis infections are more likely to be diagnosed with cancer.

New research shows that treating these viruses can reduce liver cancer risk.

A new study appears to resolve controversy over hep C treatment’s association with mortality risk.

Better treatments for hepatitis B and C and a lack of such advances for fatty liver or alcoholic liver disease are driving outcomes.

Four things you should know to be #HepAware.

Clinical trials often exclude key patient populations, including children and people living with HIV or hepatitis B or C.

More newly diagnosed cancer patients should get tested, says a new study.

We will never end the HIV and hepatitis epidemics by preventing people with preexisting conditions from accessing care.

Aflatoxin, a food-borne chemical, is probably one of the leading causes of cancer in the developing world.

A brief overview of the differences between hepatitis A, B and C.